Validity and Reliability of the Newly Developed Balance Assessment System in Healthy Young Adults
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Jan 16, 2024
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new balance assessment system to see how well it works for healthy young adults. The researchers want to determine if four specific tests—Postural Stability Test, Stability Limits Test, Sensory Integration Test, and One-Leg Standing Test—are accurate and consistent in measuring balance. Participants will take these tests on two separate days, a week apart, to ensure the results are reliable.
To participate, you need to be between 18 and 25 years old, have a healthy body weight (BMI below 24), and be able to follow instructions. It's important that you don’t have any health issues affecting balance, like certain diseases or recent injuries. If you join the study, you will sit and rest for a few minutes before performing the tests, which will help the researchers understand how well the new balance system works compared to a standard assessment device. This study is not yet recruiting participants, but it aims to gather important information about balance assessments that could benefit future evaluations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being between the ages of 18-25
- • Body mass index is below 24
- • They should be able to understand and follow instructions
- • Volunteering to participate in the study
- Exclusion Criteria:
- • Presence of neuromuscular, rheumatic disease or vestibular problems that may affect balance
- • Having a visual impairment that affects vision
- • Any other exercise or physical activity that may affect trunk muscle strength or balance
- • Having a recent history of orthopedic injury or surgery in the lower extremity
- • Having experienced any acute situation that could affect postural stability and balance between the two tests (within 7 days)
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Asena Yekdaneh
Principal Investigator
Fenerbahçe University
İrem Kurt Ulusoy
Principal Investigator
Istanbul University-Cerrahpasa, Institute of Postgraduate Education
Elçin Akyürek
Principal Investigator
Istanbul University-Cerrahpasa, Institute of Postgraduate Education
Nilay Arman
Study Chair
Istanbul University-Cerrahpaşa Faculty of Health Sciences
Ayşe Zengin Alpözgen
Principal Investigator
Istanbul University-Cerrahpaşa Faculty of Health Sciences
Bülent Bayraktar
Principal Investigator
Istanbul Faculty of Medicine, Department of Internal Medical Sciences, Department of Sports Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported